These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34976183)

  • 1. Recurrence Features and Factors influencing Post-relapse Survival in Early-stage Endometrial Cancer after Adjuvant Radiotherapy.
    Ren K; Wang W; Sun S; Wang D; Liu X; Hou X; Hu K; Zhang F
    J Cancer; 2022; 13(1):202-211. PubMed ID: 34976183
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant radiotherapy for stage I endometrial cancer.
    Kong A; Johnson N; Kitchener HC; Lawrie TA
    Cochrane Database Syst Rev; 2012 Mar; (3):CD003916. PubMed ID: 22419290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
    Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
    Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent patterns after postoperative radiotherapy for early stage endometrial cancer: A competing risk analysis model.
    Ren K; Wang W; Sun S; Hou X; Hu K; Zhang F
    Cancer Med; 2022 Jan; 11(1):257-267. PubMed ID: 34779587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer.
    Horeweg N; Nout RA; Jürgenliemk-Schulz IM; Lutgens LCHW; Jobsen JJ; Haverkort MAD; Mens JWM; Slot A; Wortman BG; de Boer SM; Stelloo E; Verhoeven-Adema KW; Putter H; Smit VTHBM; Bosse T; Creutzberg CL;
    J Clin Oncol; 2023 Sep; 41(27):4369-4380. PubMed ID: 37487144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis.
    Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
    Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy.
    Francis SR; Ager BJ; Do OA; Huang YJ; Soisson AP; Dodson MK; Werner TL; Sause WT; Grant JD; Gaffney DK
    Gynecol Oncol; 2019 Jul; 154(1):38-44. PubMed ID: 31029507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there any benefit of paraaortic field irradiation in pelvic lymph node positive endometrial cancer patients? A propensity match analysis.
    Onal C; Yuce Sari S; Akkus Yildirim B; Gultekin M; Guler OC; Yildiz F
    J Obstet Gynaecol; 2020 Oct; 40(7):1012-1019. PubMed ID: 31793400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy.
    Chapman CH; Maghsoudi K; Littell RD; Chen LM; Hsu IC
    Brachytherapy; 2017; 16(6):1152-1158. PubMed ID: 28802913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
    Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
    Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis.
    Kong A; Johnson N; Kitchener HC; Lawrie TA
    J Natl Cancer Inst; 2012 Nov; 104(21):1625-34. PubMed ID: 22962693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of intermediate-risk to high-risk stage I endometrial cancer: 10-year clinical experiences of using in-house multi-channel applicators in a single center.
    Hou XR; Yu L; Hu K; Zhang FQ
    Chin Med J (Engl); 2019 Aug; 132(16):1935-1941. PubMed ID: 31365429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Analysis of All Types of Adjuvant Radiotherapy in Endometrial Cancer: Single-Center Experiences in a Middle-Income Country.
    Chitapanarux N; Tharavichitkul E; Kittidachanan K; Muangwong P; Chakrabandhu S; Klunklin P; Onchan W; Jia-Mahasap B; Torapichattrakul P; Chitapanarux I
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):485-494. PubMed ID: 38415534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal brachytherapy for endometrial cancer.
    Hass P; Seinsch S; Eggemann H; Ignatov T; Seitz S; Ignatov A
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1523-1530. PubMed ID: 29730776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.
    Katsoulakis E; Leeman JE; Lok BH; Shi W; Zhang Z; Tsai JC; McBride SM; Sherman EJ; Cohen M; Wong R; Ganly I; Lee NY; Riaz N
    Laryngoscope; 2018 Nov; 128(11):2539-2545. PubMed ID: 29637571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.
    Sorbe B; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1249-55. PubMed ID: 21676554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Chemotherapy and Vaginal Vault Brachytherapy With or Without Pelvic Radiotherapy for Stage 1 Papillary Serous or Clear Cell Endometrial Cancer.
    Tétreault-Laflamme A; Nguyen-Huynh TV; Carrier JF; Samouëlian V; Sauthier P; Beauchemin MC; Barkati M
    Int J Gynecol Cancer; 2016 Feb; 26(2):301-6. PubMed ID: 26745699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.
    Yu KH; Leung SF; Tung SY; Zee B; Chua DT; Sze WM; Law SC; Kam MK; Leung TW; Sham JS; Lee AW; Au JS; Hui EP; Sze WK; Cheng AC; Yau TK; Ngan RK; Wong FC; Au GK; Chan AT;
    Head Neck; 2005 May; 27(5):397-405. PubMed ID: 15726589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External-beam radiotherapy and/or HDR brachytherapy in postoperative endometrial cancer patients: clinical outcomes and toxicity rates.
    De Sanctis V; Agolli L; Valeriani M; Narici S; Osti MF; Patacchiola F; Mossa B; Moscarini M; Maurizi Enrici R
    Radiol Med; 2013 Mar; 118(2):311-22. PubMed ID: 22580814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
    Chua DT; Wei WI; Sham JS; Cheng AC; Au G
    Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.